In this article, we discuss the Mark Cuban Stock Portfolio: 8 Best Stocks to Buy.
Mark Cuban is a billionaire entrepreneur, investor, and television personality whose career reflects the rags-to-riches trajectory of the American dream. Born into a working-class family in Pittsburgh, Pennsylvania, Cuban displayed an early hustle by working as a bartender and software salesman before founding his first company, MicroSolutions, which he sold to CompuServe in 1990 for $6 million. This set the stage for his most famous windfall: the sale of Broadcast.com to Yahoo! in 1999 for $5.7 billion at the height of the dot-com bubble. Following this massive exit, Cuban became a household name through high-profile investments and his long-running role as a shark on the Emmy-winning reality show Shark Tank. He is perhaps most publicly recognized for his ownership of the NBA team Dallas Mavericks.
READ MORE: 15 Under-the-Radar Picks from David Einhorn That Are Quietly Dominating 2026.
After purchasing the team in 2000 for $285 million, he transformed the franchise into a perennial winner, culminating in a 2011 NBA Championship. Although he sold his majority stake in late 2023 for around $3.5 billion, he remains a minority owner and a vocal fixture at games. In recent years, Cuban has shifted focus toward practical disruption and emerging technologies. His most significant current venture is the Mark Cuban Cost Plus Drug Company, a public benefit corporation dedicated to lowering prescription drug prices. By prioritizing transparency and sweat equity over traditional corporate structures, Cuban continues to position himself as a contrarian innovator dedicated to solving large-scale social and economic problems.
Our Methodology
It is important to clarify that the stocks listed below were picked from the public comments that Cuban has made on his investments. He has explicitly mentioned some of his private holdings during these public appearances while only alluding to others. However, based on a careful assessment of the comments, the stocks listed below largely align with his investment philosophy. Data for the hedge fund sentiment surrounding each stock was taken from Insider Monkey’s Q4 2025 database of 1041 elite hedge funds.
Why are we interested in the stocks that hedge funds pile into? The reason is simple: our research has shown that we can outperform the market by imitating the top stock picks of the best hedge funds. Our quarterly newsletter’s strategy selects 14 small-cap and large-cap stocks every quarter and has returned 498.7% since May 2014, beating its benchmark by 303 percentage points (see more details here).
Featureflash Photo Agency/Shutterstock.com
Mark Cuban Stock Portfolio: Best Stocks to Buy
8. Reading International, Inc. (NASDAQ:RDI)
Per filings from 2022, Mark Cuban was a shareholder of Reading International, Inc. (NASDAQ:RDI), a global cinema and real estate company. While he was verified through SEC filings as a 10% owner of the voting Class B shares, he has been famously quiet regarding his specific investment thesis for the company. Reading focuses on the ownership, development, and operation of entertainment and real property assets in the United States, Australia, and New Zealand. The company operates cinemas, and develops, rents, or licenses retail, commercial, and live theater assets.
READ ALSO: Lone Pine’s Non-AI Strategy Falters: 10 Non-AI Stocks Weighing Down Stephen Mandel’s 2026 Returns.
In late March, Reading International, Inc. (NASDAQ:RDI) posted earnings for the fourth quarter of 2025, reporting losses per share of $0.11, against estimates of losses per share of $0.10. The losses per share for FY25 improved to $0.62 from $1.58 in FY24. The revenue over the fourth quarter was $50.3 million, down more than 14% compared to the revenue over the same period last year. FY25 revenue stood at $203 million, against $210.5 million in FY24. The net loss for the fourth quarter widened to $2.6 million from $2.2 million. However, the FY25 net loss improved significantly to $14.1 million from $35.3 million in FY24. Adjusted EBITDA for the fourth quarter decreased to $5.1 million from $6.8 million in Q4 FY24, while FY25 adjusted EBITDA surged to $17.8 million from $2.1 million.
